TRACON Pharmaceuticals Revenue vs. Shares Outstanding

TCONDelisted Stock  USD 1.60  0.55  52.38%   
Based on TRACON Pharmaceuticals' profitability indicators, TRACON Pharmaceuticals may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess TRACON Pharmaceuticals' ability to earn profits and add value for shareholders.
For TRACON Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of TRACON Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well TRACON Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between TRACON Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of TRACON Pharmaceuticals over time as well as its relative position and ranking within its peers.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons.
Please note, there is a significant difference between TRACON Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if TRACON Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TRACON Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

TRACON Pharmaceuticals Shares Outstanding vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining TRACON Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare TRACON Pharmaceuticals value to that of its competitors to determine the firm's financial worth.
TRACON Pharmaceuticals is currently regarded number one company in revenue category among its peers. It is rated below average in shares outstanding category among its peers creating about  0.22  of Shares Outstanding per Revenue. The ratio of Revenue to Shares Outstanding for TRACON Pharmaceuticals is roughly  4.50 . Comparative valuation analysis is a catch-all model that can be used if you cannot value TRACON Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for TRACON Pharmaceuticals' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

TRACON Revenue vs. Competition

TRACON Pharmaceuticals is currently regarded number one company in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 25.98 Million. TRACON Pharmaceuticals totals roughly 12.04 Million in revenue claiming about 46% of equities under Health Care industry.

TRACON Shares Outstanding vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

TRACON Pharmaceuticals

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
12.04 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

TRACON Pharmaceuticals

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
2.68 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

TRACON Shares Outstanding Comparison

TRACON Pharmaceuticals is currently under evaluation in shares outstanding category among its peers.

TRACON Pharmaceuticals Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in TRACON Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, TRACON Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of TRACON Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of TRACON Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. TRACON Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in San Diego, California. Tracon Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.

TRACON Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on TRACON Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of TRACON Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the TRACON Pharmaceuticals' important profitability drivers and their relationship over time.

Use TRACON Pharmaceuticals in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TRACON Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TRACON Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

TRACON Pharmaceuticals Pair Trading

TRACON Pharmaceuticals Pair Trading Analysis

The ability to find closely correlated positions to TRACON Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace TRACON Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back TRACON Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling TRACON Pharmaceuticals to buy it.
The correlation of TRACON Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as TRACON Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if TRACON Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for TRACON Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your TRACON Pharmaceuticals position

In addition to having TRACON Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Target Risk ETFs Thematic Idea Now

Target Risk ETFs
Target Risk ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Risk ETFs theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Risk ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Consideration for investing in TRACON OTC Stock

If you are still planning to invest in TRACON Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TRACON Pharmaceuticals' history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk